{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:11Z","timestamp":1790043731514,"version":"4.0.1"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T00:00:00Z","timestamp":1420416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pneurobio.2014.12.001","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:38:50Z","timestamp":1420547930000},"page":"47-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle"],"prefix":"10.1016","volume":"125","author":[{"given":"S. Pablo","family":"Sardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S.","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2014.12.001_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/scitranslmed.3008659","article-title":"Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs","volume":"6","author":"Aflaki","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mds.25397","article-title":"White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations","volume":"28","author":"Agosta","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study","volume":"78","author":"Alcalay","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0025","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","article-title":"LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model","volume":"18","author":"Alegre-Abarrategui","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fneur.2012.00065","article-title":"Glucocerebrosidase involvement in Parkinson disease and other synucleinopathies","volume":"3","author":"Almeida","year":"2012","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/mds.25535","article-title":"Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation","volume":"28","author":"Angeli","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2012.08.069","article-title":"Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging","volume":"528","author":"Argyriou","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0050","doi-asserted-by":"crossref","first-page":"e21758","DOI":"10.1371\/journal.pone.0021758","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease","volume":"6","author":"Ashe","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.parkreldis.2014.09.003","article-title":"Glucocerebrosidase mutations in primary parkinsonism","volume":"20","author":"Asselta","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0065","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10545-012-9527-5","article-title":"Greater risk of parkinsonism associated with non-N370S GBA1 mutations","volume":"36","author":"Barrett","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0075","series-title":"Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease. JIMD Reports","author":"Barrett","year":"2014"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0085","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2013 macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mt.2013.281","article-title":"Parkinson's disease gene therapy: success by design meets failure by efficacy","volume":"22","author":"Bartus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/07853890.2013.849003","article-title":"Glucocerebrosidase mutations and the pathogenesis of Parkinson disease","volume":"45","author":"Beavan","year":"2013","journal-title":"Ann. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2012.06.023","article-title":"Parkinson's disease in patients and obligate carriers of Gaucher disease","volume":"19","author":"Becker","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","article-title":"Gaucher's disease with Parkinson's disease: clinical and pathological aspects","volume":"61","author":"Bembi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0110","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib3115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1474-4422(13)70047-4","article-title":"Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities","volume":"12","author":"Berg","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2141.1993.tb03185.x","article-title":"Gaucher disease mutations in non-Jewish patients","volume":"85","author":"Beutler","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2014.12.001_bib0120","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1353-8020(13)70009-9","article-title":"Genetics of Parkinson's disease \u2013 state of the art, 2013","volume":"20","author":"Bonifati","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0125","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"J. Med. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.pneurobio.2014.12.001_bib0130","first-page":"II3","article-title":"Pathoanatomy of Parkinson's disease","volume":"247","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0135","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0140","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0155","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"alpha-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burre","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2010.07.023","article-title":"Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease","volume":"225","author":"Cabrera-Salazar","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0165","doi-asserted-by":"crossref","first-page":"e43310","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"Cabrera-Salazar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0170","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jamaneurol.2013.1274","article-title":"Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations","volume":"70","author":"Chahine","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib4115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molcel.2013.01.024","article-title":"ZKSCAN3 is a master transcriptional repressor of autophagy","volume":"50","author":"Chauhan","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0180","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1194\/jlr.R047175","article-title":"Gene therapy for the neurological manifestations in lysosomal storage disorders","volume":"55","author":"Cheng","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.1245296","article-title":"Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons","volume":"342","author":"Chung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0190","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurol.2009.54","article-title":"Association of glucocerebrosidase mutations with dementia with Lewy bodies","volume":"66","author":"Clark","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0195","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0210","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson's disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0215","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/qjmed\/94.8.399","article-title":"Gaucher's disease \u2013 an exemplary monogenic disorder","volume":"94","author":"Cox","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0225","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0230","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0235","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0240","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0245","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0250","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0255","doi-asserted-by":"crossref","first-page":"e60674","DOI":"10.1371\/journal.pone.0060674","article-title":"Loss of beta-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells","volume":"8","author":"Dermentzaki","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0260","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0265","doi-asserted-by":"crossref","first-page":"e1002141","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease","volume":"7","author":"Do","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0270","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0275","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0280","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","article-title":"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration","volume":"23","author":"Farfel-Becker","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0285","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0290","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0295","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of alpha-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0300","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0305","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0310","series-title":"De l\u2019\u00e9pith\u00e9lioma primitif de la rate, hypertrophie idiopathique de la rate sans leuc\u00e9mie","author":"Gaucher","year":"1882"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0315","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and alpha-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"Ginns","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.0710685105","article-title":"The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis","volume":"105","author":"Gitler","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0335","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0340","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/brain\/aws174","article-title":"The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow","volume":"135","author":"Goker-Alpan","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0345","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0350","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0355","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0365","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease","volume":"137","author":"Hall","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0370","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0375","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1194\/jlr.M800092-JLR200","article-title":"Lipid composition of microdomains is altered in a cell model of Gaucher disease","volume":"49","author":"Hein","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0380","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mds.25349","article-title":"The role of SCARB2 as susceptibility factor in Parkinson's disease","volume":"28","author":"Hopfner","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0385","first-page":"921","article-title":"Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients","volume":"53","author":"Horowitz","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1091\/mbc.E11-06-0553","article-title":"Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase","volume":"23","author":"Jovic","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0395","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000271880.27321.a7","article-title":"Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder","volume":"69","author":"Klein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0405","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0410","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0415","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-4159.2012.07879.x","article-title":"Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease","volume":"123","author":"Kurzawa-Akanbi","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0420","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","article-title":"Extracellular alpha \u2013 synuclein-a novel and crucial factor in Lewy body diseases","volume":"10","author":"Lee","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0430","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0435","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrneurol.2010.145","article-title":"Cell-to-cell transmission of non-prion protein aggregates","volume":"6","author":"Lee","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0440","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nn.3500","article-title":"Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss","volume":"16","author":"Lee","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0445","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"Lesage","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0450","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"issue":"935","key":"10.1016\/j.pneurobio.2014.12.001_bib0455","first-page":"e933","article-title":"Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease","volume":"35","author":"Li","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0465","series-title":"Comprehensive Research Synopsis and Systematic Meta-analyses in Parkinson's Disease Genetics: The PDGene database","author":"Lill","year":"2012"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0470","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0475","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-12-104","article-title":"Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population","volume":"12","author":"Liu","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0480","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/01.wnl.0000247744.10990.e6","article-title":"Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease","volume":"68","author":"Lonser","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0485","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.1073\/pnas.1119181109","article-title":"Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0490","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0495","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0500","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bcmd.2014.04.002","article-title":"Eliglustat, an investigational oral therapy for Gaucher disease type 1: phase 2 trial results after 4years of treatment","volume":"53","author":"Lukina","year":"2014","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0505","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0510","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0515","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: from human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0520","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(07)70076-5","article-title":"Autophagy and neurodegeneration: when the cleaning crew goes on strike","volume":"6","author":"Martinez-Vicente","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0525","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0530","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0535","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.24945","article-title":"Hyposmia and cognitive impairment in Gaucher disease patients and carriers","volume":"27","author":"McNeill","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0540","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0545","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","article-title":"An ERcentric view of Parkinson's disease","volume":"19","author":"Mercado","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0550","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0555","doi-asserted-by":"crossref","first-page":"e73094","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.07.014","article-title":"VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease","volume":"71C","author":"Miura","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0565","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0570","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0965","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0580","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0585","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0590","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0595","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ymgme.2012.01.020","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice","volume":"105","author":"Nietupski","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0600","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0605","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0610","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nchembio.368","article-title":"Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis","volume":"6","author":"Ong","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0615","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nn.3350","article-title":"Interplay of LRRK2 with chaperone-mediated autophagy","volume":"16","author":"Orenstein","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0620","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0625","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of Gaucher disease \u2013 links to Parkinson's disease","volume":"17","author":"Osellame","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib9630","series-title":"An Essay on the Shaking Palsy","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0630","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0635","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/hum.2014.011","article-title":"Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy","volume":"25","author":"Passini","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0640","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11318540-000000000-00000","article-title":"Recombinant glucocerebrosidase (imiglucerase) as a therapy for Gaucher disease","volume":"24","author":"Pastores","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0645","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/jm300063b","article-title":"Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase","volume":"55","author":"Patnaik","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0650","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2014.09.041","article-title":"Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases","volume":"583","author":"Pchelina","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0655","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0660","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s40265-014-0296-3","article-title":"Eliglustat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0665","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","article-title":"Necroptosis drives motor neuron death in models of both sporadic and familial ALS","volume":"81","author":"Re","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0670","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0675","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-014-0294-x","article-title":"A GCase chaperone improves motor function in a mouse model of synucleinopathy","volume":"11","author":"Richter","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0680","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1212\/01.wnl.0000314657.92762.0f","article-title":"Gaucher and Parkinson diseases: unexpectedly related","volume":"70","author":"Rogaeva","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0685","series-title":"Probe Reports from the NIH Molecular Libraries Program: Bethesda (MD)","article-title":"Discovery, SAR, and biological evaluation of non-inhibitory chaperones of glucocerebrosidase","author":"Rogers","year":"2012"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0690","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0695","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0700","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0705","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for beta-glucocerebrosidase activity and alpha-synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0710","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0715","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0720","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000335038","article-title":"Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models","volume":"10","author":"Sardi","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0725","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib9730","series-title":"The Dementias 2","first-page":"186","article-title":"\u03b1-synuclein and synucleinopathies","author":"Schlossmacher","year":"2007"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0730","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0735","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.wnl.0000345356.40399.eb","article-title":"Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy","volume":"72","author":"Segarane","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0740","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.24045","article-title":"Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course","volume":"27","author":"Seto-Salvia","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0745","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0750","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/jnc.12672","article-title":"Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons","volume":"129","author":"Shen","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0755","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0760","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0765","first-page":"1016","article-title":"The human glucocerebrosidase gene has two functional ATG initiator codons","volume":"41","author":"Sorge","year":"1987","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib6115","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0770","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood\u2013brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib5115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0775","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/ene.12086","article-title":"No association of GBA mutations and multiple system atrophy","volume":"20","author":"Srulijes","year":"2013","journal-title":"Eur. J. Neurol"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0780","doi-asserted-by":"crossref","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0785","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0790","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","article-title":"ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease","volume":"21","author":"Tan","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0795","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.E09-09-0801","article-title":"Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs","volume":"21","author":"Thayanidhi","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0800","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.25136","article-title":"Lysosome-dependent pathways as a unifying theme in Parkinson's disease","volume":"27","author":"Tofaris","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0805","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4155\/fmc.13.14","article-title":"Glucocerebrosidase inhibitors for the treatment of Gaucher disease","volume":"5","author":"Trapero","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0810","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/hmg\/ddu178","article-title":"Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration","volume":"23","author":"Tsika","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"142","key":"10.1016\/j.pneurobio.2014.12.001_bib0815","doi-asserted-by":"crossref","first-page":"ra197","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0820","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0825","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1093\/hmg\/ddu158","article-title":"Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes","volume":"23","author":"Vacic","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0830","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0835","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of alpha-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0840","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11910-010-0102-x","article-title":"The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders","volume":"10","author":"Velayati","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0845","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilarino-Guell","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0850","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher's disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0855","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/j.neurobiolaging.2013.08.012","article-title":"Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals","volume":"35","author":"Wang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0860","doi-asserted-by":"crossref","first-page":"e61418","DOI":"10.1371\/journal.pone.0061418","article-title":"Remodeling the proteostasis network to rescue glucocerebrosidase variants by inhibiting ER-associated degradation and enhancing ER folding","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0865","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A soluble alpha-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0870","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cbpa.2013.03.023","article-title":"Bispecific antibodies for delivery into the brain","volume":"17","author":"Watts","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0875","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0880","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.7.10.1020","article-title":"Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease","volume":"7","author":"Winfield","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0885","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0890","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.celrep.2014.10.023","article-title":"iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's Disease","volume":"9","author":"Woodard","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib7115","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/brain\/awt131","article-title":"Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration","volume":"136","author":"Xilouri","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0895","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0900","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"Xu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0905","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/mt.2014.68","article-title":"Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0910","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1073\/pnas.1221046110","article-title":"Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0915","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1073\/pnas.1321341111","article-title":"Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0920","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1021\/bi401191v","article-title":"Saposin C protects glucocerebrosidase against alpha-synuclein inhibition","volume":"52","author":"Yap","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0925","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0930","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"Yap","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0935","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/ncomms4828","article-title":"Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy","volume":"5","author":"Zavodszky","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0945","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2011.06.019","article-title":"Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion","volume":"231","author":"Ziegler","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0950","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0955","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.pneurobio.2014.12.001_bib0960","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awu143","article-title":"Visual short-term memory deficits associated with GBA mutation and Parkinson's disease","volume":"137","author":"Zokaei","year":"2014","journal-title":"Brain"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008214001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008214001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T08:35:15Z","timestamp":1566203715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008214001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":198,"alternative-id":["S0301008214001361"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2014.12.001","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}